<p>防禦性投資在高飛的半導體反彈中被拋在了後面，許多個別行業落後於市場。</p>
<p>儘管在伊朗戰爭開始後經歷了一次令人震驚的修正，標準普爾 500 指數目前年初至今（YTD）上漲約 10%。但這次反彈相對狹窄，市場在與人工智能相關的股票和沒有人工智能相關的股票之間出現了明顯分化，這使得保險行業處於危險境地。然而，並不是所有的保險股票都落後於市場。</p>
<p>事實上，一些股票正在創下 52 周新高，主要是因為它們避免了一個變得極具問題的市場細分：財產和意外險。</p>
<p>觀察一對保險 ETF 可以看出市場的分化情況。iShares 美國保險 ETF NYSE: IAK 年初至今下跌約 2%，而 Invesco KBW 財產和意外險 ETF NASDAQ: KBWP 在 2026 年迄今下跌超過 5%。</p>
<p>商業財產和意外險定價是分化的主要原因。根據保險代理人和經紀人協會的數據，2026 年第一季度商業財產和意外險保費下降了 1.2%，這是自 2017 年以來首次出現保費價格下降的季度。財產保費受到的打擊最大，下降了 5.8%，與前兩個時期相比加速顯著。</p>
<p>保險指數嚴重依賴於大型財產和意外險承保公司，如 Progressive Corp. NYSE: PGR、Chubb Ltd. NYSE: CB 和 Travelers Companies Inc. NYSE: TRV，這些公司正處於價格週期軟化的瞄準範圍內。但生命、團體福利和補充健康領域的公司則免受商業財產和意外險價格下跌的影響。在財產和意外險價格週期回落的同時，價值和福利行業仍然被低估，這正是我們將在這裏探討的股票選擇領域。</p>
<p>在這個週期中挑選保險股票的關鍵主題是與商業財產和意外險領域的隔離。以下三家公司在財產和意外險方面的暴露較小，並且在主要指數中的存在有限（或沒有）。</p>
<h2>大都會人壽：多元化複合型公司，強勁的股息</h2>
<p>大都會人壽公司 NYSE: MET 是這裏唯一一隻在指數中佔有顯著權重的保險股票（約佔 IAK 持股的 5%），但不能因此歸咎於其表現不佳。</p>
<p>MET 的股票在過去三個月上漲超過 17%，主要受到廣泛的盈利超預期和股息增加的推動。</p>
<p>在公司於 5 月 6 日發佈的 2026 年第一季度財報中，大都會人壽報告調整後收益為 16 億美元，調整後每股收益為 2.42 美元，分別增長 18% 和 23%。公司還向股東回購和分紅超過 10 億美元。股息在增加後現在每年支付 2.37 美元，連續第 12 年增加。</p>
<p>該股票在最終突破約 83 美元的多年阻力位後也展現出動能。相對強弱指數（RSI）確認了看漲動能，表明這一突破可能具有持續性。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144032_met2026-06-0414-45-45.PNG?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144032_met2026-06-0414-45-45.PNG"/></p>
<h2>Globe Life：深度價值逃離指數下跌</h2>
<p>Globe Life Inc. NYSE: GL 專注於為低收入和中等收入家庭提供生命和補充健康保險。</p>
<p>雖然中端市場的生命和補充保險並不是高增長行業，但它們確實提供穩定、長期的現金流，不易受到週期性影響。</p>
<p>該公司報告的 2026 年第一季度業績大致符合市場預期，管理層將全年的運營每股收益指引上調至 15.40-15.90 美元。這裏不需要一份爆炸性的報告，股票的交易僅為未來收益的 10 倍，遠低於保險行業（12 倍收益）和標準普爾 500（22 倍收益）的水平。</p>
<p>圖表也顯示出一些積極的技術動能。現在 RSI 穩固在看漲區域，股票突破 50 日移動平均線可能是可持續的。以前的阻力區域在突破時往往會變成支撐，而 50 日移動平均線似乎成為 GL 股票的新分界線。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144353_gl2026-06-0414-47-30.PNG?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144353_gl2026-06-0414-47-30.PNG"/></p>
<h2>Unum Group：低風險、高收益的就業保險公司</h2>
<p>Unum Group NYSE: UNM 儘管其穩定的就業相關和團體殘疾承保公司（如 Colonial Life）未能在主要指數中佔有一席之地，但它的表現值得關注。指數提供商可能想要糾正這個錯誤，因為這家公司可能是其中最具性價比的選擇。</p>
<p>該股票的交易僅為未來收益的 9 倍和銷售額的 1.06 倍，儘管在過去三個月上漲了 16%，受益於 2026 年第一季度的業績超預期。收入同比增長 8%，主要得益於長期護理領域風險的減弱，管理層連續第 17 年提高了股息。</p>
<p>一家低貝塔的保險公司，擁有強勁的股息和去風險的敍述，就像價值投資者的飛蛾撲向燈光。該股票正處於健康的突破之中，創下新高，並在 50 日和 200 日移動平均線形成金叉。RSI 也在配合，保持其看漲水平而未突破超買閾值。這個低調的複合型機器可能會迎來更多新高。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144832_unm2026-06-0414-57-20.PNG?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144832_unm2026-06-0414-57-20.PNG"/></p>
<h2>你現在應該投資 1000 美元在大都會人壽嗎？</h2>
<p>在考慮大都會人壽之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場意識到之前購買……而大都會人壽並不在名單上。</p>
<p>儘管大都會人壽目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

UNUM保險

大都會人壽

<p>大都會人壽、Globe Life 和 UNUM 保險在 52 周內創下新高，因為在生命和健康保險領域的公司表現優於財產和意外險（P&C）公司。2026 年第一季度，商業 P&C 保費下降，拖累了以 P&C 為主的指數。相反，這三隻股票受益於與 P&C 價格週期的隔離，報告了強勁的第一季度收益、股息增長和技術突破，使它們在市場分化中成為有吸引力的防禦性投資</p>

<p>Defensive investing has been left in the dust by the high-flying semiconductor rally, and plenty of individual sectors are lagging the market.</p>
<div class="lb-trans"><p>防禦性投資在高飛的半導體反彈中被拋在了後面，許多個別行業落後於市場。</p>
</div><p>Despite a whiplash-inducing correction following the start of the Iran war, the S&amp;P 500 is now up around 10% year-to-date (YTD). But the rally has been narrow, and the market has become sharply divided between stocks with AI connections and those without, which puts the insurance sector in perilous territory. However, not every insurance stock is lagging the market.</p>
<div class="lb-trans"><p>儘管在伊朗戰爭開始後經歷了一次令人震驚的修正，標準普爾 500 指數目前年初至今（YTD）上漲約 10%。但這次反彈相對狹窄，市場在與人工智能相關的股票和沒有人工智能相關的股票之間出現了明顯分化，這使得保險行業處於危險境地。然而，並不是所有的保險股票都落後於市場。</p>
</div><p>In fact, some are making new 52-week highs, in large part because they’re avoiding a certain niche of the market that’s becoming highly problematic: property and casualty.</p>
<div class="lb-trans"><p>事實上，一些股票正在創下 52 周新高，主要是因為它們避免了一個變得極具問題的市場細分：財產和意外險。</p>
</div><p>A look into a pair of insurance ETFs shows where the market has become bifurcated. The iShares U.S. Insurance ETF NYSE: IAK is down about 2% YTD, but the Invesco KBW Property and Casualty ETF NASDAQ: KBWP is down more than 5% so far in 2026.</p>
<div class="lb-trans"><p>觀察一對保險 ETF 可以看出市場的分化情況。iShares 美國保險 ETF NYSE: IAK 年初至今下跌約 2%，而 Invesco KBW 財產和意外險 ETF NASDAQ: KBWP 在 2026 年迄今下跌超過 5%。</p>
</div><p>Commercial P&amp;C pricing is the main culprit of the divergence. According to the Council of Insurance Agents and Brokers, commercial P&amp;C premiums fell 1.2% in Q1 2026, marking the first quarter of premium price declines since 2017. Property premiums took the biggest hit, dropping 5.8% in a “notable acceleration” from the previous two periods.</p>
<div class="lb-trans"><p>商業財產和意外險定價是分化的主要原因。根據保險代理人和經紀人協會的數據，2026 年第一季度商業財產和意外險保費下降了 1.2%，這是自 2017 年以來首次出現保費價格下降的季度。財產保費受到的打擊最大，下降了 5.8%，與前兩個時期相比加速顯著。</p>
</div><p>The insurance indices are heavily weighted toward large-cap P&amp;C carriers like Progressive Corp. NYSE: PGR, Chubb Ltd. NYSE: CB, and Travelers Companies Inc. NYSE: TRV that sit in the crosshairs of the softening price cycle. But companies in the life, group benefits, and supplemental health segments are sheltered from commercial P&amp;C price declines. While the P&amp;C price cycle rolls over, the value and benefits industry continues to be undervalued, and that’s exactly the area we’re going to explore with our stock selections here.</p>
<div class="lb-trans"><p>保險指數嚴重依賴於大型財產和意外險承保公司，如 Progressive Corp. NYSE: PGR、Chubb Ltd. NYSE: CB 和 Travelers Companies Inc. NYSE: TRV，這些公司正處於價格週期軟化的瞄準範圍內。但生命、團體福利和補充健康領域的公司則免受商業財產和意外險價格下跌的影響。在財產和意外險價格週期回落的同時，價值和福利行業仍然被低估，這正是我們將在這裏探討的股票選擇領域。</p>
</div><p>The key theme when picking insurance stocks in this cycle is insulation from the commercial P&amp;C segment. Each of the following three firms has little P&amp;C exposure and a limited (or no) presence in the major indices.</p>
<div class="lb-trans"><p>在這個週期中挑選保險股票的關鍵主題是與商業財產和意外險領域的隔離。以下三家公司在財產和意外險方面的暴露較小，並且在主要指數中的存在有限（或沒有）。</p>
</div><h2>MetLife: Diversified Compounder With Strong Dividend</h2>
<div class="lb-trans"><h2>大都會人壽：多元化複合型公司，強勁的股息</h2>
</div><p>MetLife Inc. NYSE: MET is the only insurance stock listed here with a significant weight in the indices (about 5% of IAK’s holdings), but it can’t be blamed for the poor performance.</p>
<div class="lb-trans"><p>大都會人壽公司 NYSE: MET 是這裏唯一一隻在指數中佔有顯著權重的保險股票（約佔 IAK 持股的 5%），但不能因此歸咎於其表現不佳。</p>
</div><p>MET shares are up more than 17% in the last three months, driven by a broad earnings beat and dividend raise.</p>
<div class="lb-trans"><p>MET 的股票在過去三個月上漲超過 17%，主要受到廣泛的盈利超預期和股息增加的推動。</p>
</div><p>In the company’s Q1 2026 numbers released on May 6, MetLife reported adjusted earnings of $1.6 billion and adjusted EPS of $2.42, up 18% and 23% respectively. The company also returned more than $1 billion to shareholders in buybacks and dividends. The dividend now pays $2.37 per share annually following the raise, the 12th consecutive year of payout increases.</p>
<div class="lb-trans"><p>在公司於 5 月 6 日發佈的 2026 年第一季度財報中，大都會人壽報告調整後收益為 16 億美元，調整後每股收益為 2.42 美元，分別增長 18% 和 23%。公司還向股東回購和分紅超過 10 億美元。股息在增加後現在每年支付 2.37 美元，連續第 12 年增加。</p>
</div><p>The stock also has momentum after finally breaking through a multi-year resistance level around $83. The Relative Strength Index (RSI) confirms the bullish momentum, indicating that this breakout could have staying power.</p>
<div class="lb-trans"><p>該股票在最終突破約 83 美元的多年阻力位後也展現出動能。相對強弱指數（RSI）確認了看漲動能，表明這一突破可能具有持續性。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144032_met2026-06-0414-45-45.PNG" alt="" original-src="https://www.marketbeat.com/logos/articles/med_20260604144032_met2026-06-0414-45-45.PNG"/></p>
<h2>Globe Life: Deep Value Escaping the Index Drawdown</h2>
<div class="lb-trans"><h2>Globe Life：深度價值逃離指數下跌</h2>
</div><p>Globe Life Inc. NYSE: GL focuses on life and supplemental health insurance for lower and middle-income households.</p>
<div class="lb-trans"><p>Globe Life Inc. NYSE: GL 專注於為低收入和中等收入家庭提供生命和補充健康保險。</p>
</div><p>While mid-market life and supplemental insurance aren’t high-growth industries, they do provide steady, long-duration cash flows that aren’t prone to cyclicality.</p>
<div class="lb-trans"><p>雖然中端市場的生命和補充保險並不是高增長行業，但它們確實提供穩定、長期的現金流，不易受到週期性影響。</p>
</div><p>The company reported Q1 2026 results approximately in line with market expectations, and management raised full-year operating EPS guidance to $15.40-$15.90. No need for a blowout report here, with the stock trading at just 10x forward earnings, a steep discount to both the insurance sector (12x earnings) and the S&amp;P 500 (22x earnings).</p>
<div class="lb-trans"><p>該公司報告的 2026 年第一季度業績大致符合市場預期，管理層將全年的運營每股收益指引上調至 15.40-15.90 美元。這裏不需要一份爆炸性的報告，股票的交易僅為未來收益的 10 倍，遠低於保險行業（12 倍收益）和標準普爾 500（22 倍收益）的水平。</p>
</div><p>The chart is showing some positive technical momentum as well. Now that the RSI is firmly in bullish territory, the stock’s breakout above the 50-day moving average could be sustainable. Former resistance areas often become support during breakouts, and the 50-day MA appears to be a new line in the sand for GL shares.</p>
<div class="lb-trans"><p>圖表也顯示出一些積極的技術動能。現在 RSI 穩固在看漲區域，股票突破 50 日移動平均線可能是可持續的。以前的阻力區域在突破時往往會變成支撐，而 50 日移動平均線似乎成為 GL 股票的新分界線。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144353_gl2026-06-0414-47-30.PNG" alt="" original-src="https://www.marketbeat.com/logos/articles/med_20260604144353_gl2026-06-0414-47-30.PNG"/></p>
<h2>Unum Group: Low-Risk, High-Yield Employment Insurer</h2>
<div class="lb-trans"><h2>Unum Group：低風險、高收益的就業保險公司</h2>
</div><p>Unum Group NYSE: UNM also lacks representation in the major indices despite its steady franchise of employment-linked and group disability carriers, such as Colonial Life. Index providers may want to remedy this mistake, as this company may be the best bargain of the bunch.</p>
<div class="lb-trans"><p>Unum Group NYSE: UNM 儘管其穩定的就業相關和團體殘疾承保公司（如 Colonial Life）未能在主要指數中佔有一席之地，但它的表現值得關注。指數提供商可能想要糾正這個錯誤，因為這家公司可能是其中最具性價比的選擇。</p>
</div><p>The stock trades at just 9x forward earnings and 1.06x sales despite a 16% gain over the last three months, boosted by a top- and bottom-line Q1 2026 earnings beat. Revenue grew 8% year-over-year (YOY), largely due to fading risk in the long-term care segment, and management boosted the dividend for the 17th consecutive year.</p>
<div class="lb-trans"><p>該股票的交易僅為未來收益的 9 倍和銷售額的 1.06 倍，儘管在過去三個月上漲了 16%，受益於 2026 年第一季度的業績超預期。收入同比增長 8%，主要得益於長期護理領域風險的減弱，管理層連續第 17 年提高了股息。</p>
</div><p>A low-beta insurer with a strong dividend and a derisking narrative is like a lightbulb for value-investing moths. The stock is in the midst of a healthy breakout, notching new all-time highs with a Golden Cross forming at the 50-day and 200-day MAs. The RSI is also cooperating, maintaining its bullish level without crossing the Overbought threshold. More highs are likely on the way for this under-the-radar compounding machine.</p>
<div class="lb-trans"><p>一家低貝塔的保險公司，擁有強勁的股息和去風險的敍述，就像價值投資者的飛蛾撲向燈光。該股票正處於健康的突破之中，創下新高，並在 50 日和 200 日移動平均線形成金叉。RSI 也在配合，保持其看漲水平而未突破超買閾值。這個低調的複合型機器可能會迎來更多新高。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260604144832_unm2026-06-0414-57-20.PNG" alt="" original-src="https://www.marketbeat.com/logos/articles/med_20260604144832_unm2026-06-0414-57-20.PNG"/></p>
<h2>Should You Invest $1,000 in MetLife Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在大都會人壽嗎？</h2>
</div><p>Before you consider MetLife, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮大都會人壽之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場意識到之前購買……而大都會人壽並不在名單上。</p>
</div><p>While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>儘管大都會人壽目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

這三隻保險股創下 52 周新高：現在是否仍有購買的機會？